Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
SHANGHAI, CHINA – NOVEMBER 05: People visit the booth of Organon during the 7th China International Import Expo (CIIE) at…
Tag: drugmaker
Novo Nordisk’s stock rallied after drugmaker reveals deal with OpenAI
Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new…
Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026
The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook. www.marketwatch.com #Novo #Nordisks #stock #tumbles…
Democratic Senators Demand Details on Trump’s Drugmaker Deals
Democratic senators are demanding more details on the drug pricing deals that Pfizer Inc., Eli Lilly & Co. and others…
Is GLP-1 the new AI? Drugmaker Eli Lilly joins the $1 trillion market-cap club.
Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone. www.marketwatch.com…
CEO of drugmaker Amgen talks new results from cholesterol drug trial
Amgen CEO Bob Bradway detailed promising results from the company’s recent drug trial, telling CNBC’s Jim Cramer that the medicine…
Pfizer Sues to Block Novo Bid for Obesity Drugmaker Metsera
Pfizer Inc. sued Metsera Inc. and rival drugmaker Novo Nordisk A/S to block the Danish company’s rival bid for the…
Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billion
Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in…
Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims…
AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market.
AstraZeneca looks poised to announce a deal with U.S. President Donald Trump that’s focused on lowering drug prices, in a…